关键信息
-
基因名
BMPR1A/ALK-3
- 应用
-
别名
Activin receptor-like kinase 3 ;ALK-3Serine/threonine-protein kinase receptor R5 ;SKR5; CD292
-
种属
Human
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P36894
-
表达区间
177-532aa
-
分子量
56.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
BMPR1A, also known as ALK-3, is a receptor that plays a crucial role in bone morphogenetic protein (BMP) signaling pathways, which are essential for various biological processes including embryonic development, tissue regeneration, and bone formation. Dysregulation of BMPR1A signaling has been implicated in a range of diseases, including pulmonary arterial hypertension and certain cancers. Recent research has focused on the functional characterization of recombinant BMPR1A/ALK-3 proteins to better understand their structural properties and interactions with ligands. These recombinant proteins are valuable tools for elucidating the mechanism of BMP signaling and the downstream effects on cellular processes. Studies often include the examination of BMPR1A's role in modulating Smad-dependent and Smad-independent pathways, and how mutations or alterations in this receptor can affect cellular responses to BMPs. The development of effective therapeutic strategies targeting BMPR1A may provide new avenues for treating conditions related to abnormal BMP signaling. Understanding the structure and function of recombinant BMPR1A/ALK-3 will help in the design of novel drugs and therapies that can restore normal signaling pathways disrupted in disease states.
